Gross Margin

A new study shows a 147% jump in 2025 e-commerce orders, but a small group of elite brands captured most gains by mastering automation and adapting to new shopper habits.

As it nears its 100th anniversary, Valley Bank is launching a major campaign to blend its legacy of personal service with modern financial power.

Entegris confirms its quarterly dividend, a sign of financial stability. But what does this move reveal about its debt reduction, growth, and industry position?

As BD enters a new growth phase with interim leadership, the MedTech giant brings in Shawn Bevec, whose unique background bridges lab science and Wall Street.

Himel secures top global awards for its low-voltage products and EV charger, cementing its role as a key innovator in the global energy transition.

Winnebago Industries' latest report reveals major strides in sustainability, safety, and community impact, signaling a strategic shift in outdoor recreation.

The biopharma firm projects massive sales from its current drugs and bets big on a new Alzheimer's therapy, signaling a pivotal year of growth and innovation.

Vericel posts strong 2025 results driven by its MACI cartilage therapy. The biotech leader is now investing in a new facility and a clinical trial for ankle repair.

Medical device firm CVRx is under investigation after its stock nosedived. Did management mislead investors about its salesforce stability?

TNL Mediagene's GIZMART platform and Keychron smash crowdfunding records, proving editorial trust can be a powerful driver of direct-to-consumer sales.

The first-ever Wegovy pill is now available via telehealth platform Ro, offering a cash-pay option that could revolutionize access to weight loss drugs.

OpenText divests its on-premise eDOCS unit to NetDocuments, using the cash for debt reduction while sharpening its focus on AI and cloud services.

Amid rapid industry consolidation, doctor-owned DSO PepperPointe Partnerships adds three VPs to scale its unique model and support continued expansion.

This strategic acquisition combines AI-driven tech with deep clinical expertise to help hospitals fight rising claim denials and severe margin pressure.

Inogen reports modest growth and a pivotal return to positive EBITDA, yet a revenue miss from delayed B2B orders raises questions for its turnaround.

New 2025 data reveals an AI platform is slashing costs, improving chronic disease outcomes, and closing health equity gaps for hundreds of clinicians.

Kyle Addington of American Wealth Advisers joins IFG's new advisory council, giving local clients a voice in the future of financial services nationwide.

Carlsmed's AI-driven aprevo® platform shows massive surgeon adoption and market growth, signaling a new era of personalized, cost-effective spine care.

With preliminary Q1 revenue of $103.7M, Twist Bioscience beats forecasts, setting a bullish tone ahead of its full earnings report on February 2nd.

The genomics leader posted a 41% revenue surge in 2025 and projects profitability, yet its stock tumbled on what some see as conservative 2026 guidance.